Intensive chemotherapy with autologous peripheral blood stem cell transplantation during a 10-year period in 64 patients with germ cell tumor

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Antonia M S MüllerMonika Engelhardt

Abstract

Despite gratifying cure rates in germ cell tumors, conventional-dose chemotherapy achieves long-term remissions in less than 50% of patients at high risk. High-dose chemotherapy followed by autologous (auto) peripheral blood stem cell transplantation (PBSCT) has shown impressive remission rates in high-risk and relapsed germ cell tumors. We report on 64 consecutive patients with high- (n=39), intermediate- (n=18), and refractory or relapsed low- (n=7) risk germ cell tumors who underwent auto-PBSCT between January 1993 and February 2003. PBSCTs were performed as a single (n=40) or repeated (n=24) transplantation using either etoposide, ifosfamide, and carboplatin (n=80) or related protocols (paclitaxel, ifosfamide, carboplatin, etoposide [n=7]; carboplatin, etoposide, thiotepa [n=4]). With a median follow-up of 6 years, estimated 2- and 5-year overall survivals were 77.2% (95% confidence interval [CI] 66.7-87.7) and 73.1% (95% CI 61.7-84.5), respectively. We observed unfavorable results in those patients showing refractoriness to cisplatin (hazard ratio 20.36; 95% CI 6.64-62.47) or no response to induction chemotherapy (hazard ratio 10.67; 95% CI 1.37-83.37). Auto-PBSCT was well tolerated, showed objective antitumor activity, an...Continue Reading

References

Jan 1, 1981·Cancer·A B MillerA Winkler
Jul 24, 1997·The New England Journal of Medicine·G J Bosl, R J Motzer
Feb 19, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·O RickW Siegert
Mar 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carsten BokemeyerJörg T Hartmann
Jun 12, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J BeyerW Siegert
Nov 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel A VaenaLawrence H Einhorn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
O RickW Siegert
International Journal of Urology : Official Journal of the Japanese Urological Association
Tsuneharu MikiJapan Blood Cell Transplantation Study Group for Testicular Germ Cell Tumor
© 2021 Meta ULC. All rights reserved